| Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins |
22 |
| PARP Inhibitors in Ovarian Cancer |
19 |
| Repurposing Disulfiram as An Anti-Cancer Agent: Updated Review on Literature and Patents |
16 |
| The Application of lncRNAs in Cancer Treatment and Diagnosis |
16 |
| Advances in the Discovery of Anthraquinone-Based Anticancer Agents |
15 |
| Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy |
14 |
| PARP Inhibitors in Epithelial Ovarian Cancer |
12 |
| Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Micro-environment |
7 |
| Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches |
7 |
| HMGA and Cancer: A Review on Patent Literatures |
6 |
| Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer |
6 |
| A Truncated Snail1 Transcription Factor Alters the Expression of Essential EMT Markers and Suppresses Tumor Cell Migration in a Human Lung Cancer Cell Line |
6 |
| Oral Submucous Fibrosis as an Overhealing Wound: Implications in Malignant Transformation |
5 |
| Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents |
5 |
| From Antimicrobial to Anticancer Peptides: The Transformation of Peptides |
5 |
| Death-Associated Protein Kinase 1 as a Promising Drug Target in Cancer and Alzheimer's Disease |
5 |
| New Anti-Cancer Strategies in Testicular Germ Cell Tumors |
4 |
| Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments |
4 |
| Novel Small Molecule Inhibitors of Programmed Cell Death (PD)- and its Ligand, PD-L1 in Cancer Immunotherapy: A Review Update of Patent Literature |
4 |
| Cucurbitacins as Anticancer Agents: A Patent Review |
4 |
| Lentiviral-Mediated Overexpression of MicroRNA-141 Promotes Cell Proliferation and Inhibits Apoptosis in Human Esophageal Squamous Cell Carcinoma |
4 |
| Anti-Oxidants as Chemopreventive Agents in Prostate Cancer: A Gap Between Preclinical and Clinical Studies |
4 |
| Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy |
4 |
| NLRP3 Inflammasome Activation Inhibitors in Inflammation-Associated Cancer Immunotherapy: An Update on the Recent Patents |
3 |
| Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature |
3 |
| Anaplastic Lymphoma Kinase in Glioblastoma: Detection/Diagnostic Methods and Therapeutic Options |
3 |
| Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature |
3 |
| Amplified Crosstalk Between Estrogen Binding and GFR Signaling Mediated Pathways of ER Activation Drives Responses in Tumors Treated with Endocrine Disruptors |
3 |
| Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds |
3 |
| Synthesis and DFT Study on Hantzsch Reaction to Produce Asymmetrical Compounds of 4-Dihydropyridine Derivatives for P-Glycoprotein Inhibition as Anticancer Agent |
3 |
| Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents |
2 |
| Recent Progress of Marine Polypeptides as Anticancer Agents |
2 |
| Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of the Art and New Perspectives with Patents Recently Applied |
2 |
| The Epithelial-Mesenchymal Transition Pathway in Two Cases with Gastric Metastasis Originating from Breast Carcinoma, One with a Metachronous Primary Gastric Cancer |
2 |
| Evolving Strategies for the Treatment of T-Cell Lymphoma: A Systematic Review and Recent Patents |
2 |
| Low Dose of Acacetin Promotes Breast Cancer MCF-7 Cells Proliferation Through the Activation of ERK/PI3K/AKT and Cyclin Signaling Pathway |
2 |
| Apigenin, A Plant Flavone Playing Noble Roles in Cancer Prevention Via Modulation of Key Cell Signaling Networks |
2 |
| MDM2-p53 Interaction inhibitors: The Current State-of-Art and Updated Patent Review (2010-Present) |
1 |
| CS A Novel Marine Polypeptide, Inhibits Migration and Invasion of Cancer Cells Via Interacting with Enolase 1 |
1 |
| Emerging Drugs for the Treatment of Breast Cancer Brain Metastasis: A Review of Patent Literature |
1 |
| Stemness Phenotype in Tamoxifen Resistant Breast Cancer Cells May be Induced by Interactions Between Receptor Tyrosine Kinases and ER alpha-66 |
1 |
| Tissue Distribution and Systemic Toxicity Evaluation of Raloxifene Targeted Polymeric Micelles of Poly (Styrene-Maleic Acid)-Poly (Amide-Ether-Ester-Imide)-Poly (Ethylene Glycol) Loaded With Docetaxel in Breast Cancer Bearing Mice |
1 |
| Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer |
1 |
| Chimeric Antigen Receptor T Cell Immunotherapy for Tumor: A Review of Patent Literatures |
1 |
| Journey Describing the Cytotoxic Potential of Withanolides: A Patent Review |
1 |
| Enzyme and Transporter Kinetics for CPT-11 (Irinotecan) and SN-38: An Insight on Tumor Tissue Compartment Pharmacokinetics Using PBPK |
1 |
| Inhibitory Effect of Hydroxysafflor Yellow B on the Proliferation of Human Breast Cancer MCF-7 Cells |
1 |
| Anti-Cancer Effect of alpha-Solanine by Down-Regulating S100P Expression in Colorectal Cancer Cells |
1 |
| Strategies to Tackle Radiation Resistance by Penetrating Cancer Stem Cell Line of Scrimmage |
0 |
| Reduced Lipocalin 2 Expression Contributes to Vincristine Resistance in Human Colon Cancer Cells |
0 |
